SOFOCRUZ LP (90mg + 400mg) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Torrent Pharmaceuticals Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ledipasvir, Sofosbuvir. This drug comes in the form of Tablet.
Indication (Prescribed for or used as): Sofosbuvir is used along with ribavirin (Copegus, Rebetol) and sometimes another medication (peginterferon alfa [Pegasys] to treat chronic hepatitis C (an ongoing viral infection that damages the liver). Sofosbuvir is also used along with ribavirin (&nmp) in people with liver cancer and hepatitis C infection who are waiting for a liver transplant to treat hepatitis C infection and to decrease the risk of reinfection after the transplant. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Sofosbuvir may not prevent the spread of hepatitis C to other people.
There are 12 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for SOFOCRUZ LP (90mg + 400mg), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ledipasvir-90 mg Sofosbuvir-400 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used &nmp to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include &nmp the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.